ANTAGONIST - 77 Annonces

Tuesday 08 July 2025

Quantité : 1kg; 25kg;

Clemastine fumarate is a potent, long-acting, fast-acting, highly selective histamine H1 receptor antagonist that simultaneously blocks H1 receptors and antagonizes cytotoxicity. It is mainly used clinically for allergic diseases such as allergic skin diseases and allergic rhinitis...

Thursday 03 July 2025

Quantité : 1kg; 25kg;

Maropitant citrate hydrate is a synthetic compound that has emerged as a significant medication in veterinary medicine, particularly for its antiemetic properties. The discovery of maropitant can be traced back to the early 2000s, when researchers aimed to develop new agents that...

Tuesday 01 July 2025

Atosiban is a combined receptor antagonist of contractin and pressor V1A. The structure of contractin receptor and pressor V1A receptor is similar. When the contractin receptor is blocked, the contractin can still act through the V1A receptor, so it is necessary to block both of the...

Tuesday 01 July 2025

Cetrorelix acetate is a synthetic decapeptide that is mainly used in assisted reproductive technology to prevent early ovulation in patients with controlled ovarian stimulation.Cetrorelix acetate, also commonly known as cetrorelix, is a gonadotropin-releasing hormone (GnRH) antagonist...

Tuesday 01 July 2025

Ganirelix is a synthetic decapeptide compound whose acetate, Ganirelix Acetate, is a gonadotropin-releasing hormone (GnRH) receptor antagonist. The amino acid sequence is Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-Tyr-D-HomoAr g(9,10-Et2)-Leu-L-HomoArg(9,10-Et2)-Pro- D-Ala-NH2.It is used clinically...

Tuesday 01 July 2025

Degarelix acetate is a synthetic gonadotropin-releasing hormone (GnRH) receptor antagonist that exerts its anti-prostate cancer effects by reversibly binding to GnRH receptors in the pituitary gland, reducing the release of gonadotropins and testosterone. Brand: Soarwin EC Number...

Tuesday 01 July 2025

Lacosamide is a novel NMDA receptor glycine site binding antagonist, belonging to a new class of functional amino acids, and an anticonvulsant drug with a new dual mechanism of action. It can selectively promote the slow inactivation of sodium channels and regulate collapse response...

Tuesday 01 July 2025

Clemastine fumarate is a potent, long-acting, fast-acting, highly selective histamine H1 receptor antagonist that simultaneously blocks H1 receptors and antagonizes cytotoxicity. It is mainly used clinically for allergic diseases such as allergic skin diseases and allergic rhinitis...

Saturday 28 June 2025

Tianeptine FA cas 72797-41-2 has antidepressant and anxiolytic (anti-anxiety) properties with a relative lack of sedative, anticholinergic and cardiovascular adverse effects, thus suggesting it is particularly suitable for use in the elderly and in those following withdrawal; such...

Saturday 28 June 2025

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Saturday 28 June 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Wednesday 25 June 2025

Ganirelix is a synthetic decapeptide compound whose acetate, Ganirelix Acetate, is a gonadotropin-releasing hormone (GnRH) receptor antagonist. The amino acid sequence is Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-Tyr-D-HomoAr g(9,10-Et2)-Leu-L-HomoArg(9,10-Et2)-Pro- D-Ala-NH2.It is used clinically...

Wednesday 25 June 2025

Degarelix acetate is a synthetic gonadotropin-releasing hormone (GnRH) receptor antagonist that exerts its anti-prostate cancer effects by reversibly binding to GnRH receptors in the pituitary gland, reducing the release of gonadotropins and testosterone. Brand: Soarwin EC Number...

Tuesday 24 June 2025

Atosiban is a combined receptor antagonist of contractin and pressor V1A. The structure of contractin receptor and pressor V1A receptor is similar. When the contractin receptor is blocked, the contractin can still act through the V1A receptor, so it is necessary to block both of the...

Tuesday 24 June 2025

Cetrorelix acetate is a synthetic decapeptide that is mainly used in assisted reproductive technology to prevent early ovulation in patients with controlled ovarian stimulation.Cetrorelix acetate, also commonly known as cetrorelix, is a gonadotropin-releasing hormone (GnRH) antagonist...

Tuesday 24 June 2025

Ganirelix is a synthetic decapeptide compound whose acetate, Ganirelix Acetate, is a gonadotropin-releasing hormone (GnRH) receptor antagonist. The amino acid sequence is Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-Tyr-D-HomoAr g(9,10-Et2)-Leu-L-HomoArg(9,10-Et2)-Pro- D-Ala-NH2.It is used clinically...

Tuesday 24 June 2025

Degarelix acetate is a synthetic gonadotropin-releasing hormone (GnRH) receptor antagonist that exerts its anti-prostate cancer effects by reversibly binding to GnRH receptors in the pituitary gland, reducing the release of gonadotropins and testosterone. Brand: Soarwin EC Number...

Saturday 21 June 2025

Lacosamide is a novel NMDA receptor glycine site binding antagonist, belonging to a new class of functional amino acids, and an anticonvulsant drug with a new dual mechanism of action. It can selectively promote the slow inactivation of sodium channels and regulate collapse response...

Saturday 21 June 2025

Clemastine fumarate is a potent, long-acting, fast-acting, highly selective histamine H1 receptor antagonist that simultaneously blocks H1 receptors and antagonizes cytotoxicity. It is mainly used clinically for allergic diseases such as allergic skin diseases and allergic rhinitis...

Friday 13 June 2025

Maropitant citrate hydrate is a synthetic compound that has emerged as a significant medication in veterinary medicine, particularly for its antiemetic properties. The discovery of maropitant can be traced back to the early 2000s, when researchers aimed to develop new agents that...

Thursday 12 June 2025

Tianeptine FA cas 72797-41-2 has antidepressant and anxiolytic (anti-anxiety) properties with a relative lack of sedative, anticholinergic and cardiovascular adverse effects, thus suggesting it is particularly suitable for use in the elderly and in those following withdrawal; such...

Thursday 12 June 2025

Lacosamide is a novel NMDA receptor glycine site binding antagonist, belonging to a new class of functional amino acids, and an anticonvulsant drug with a new dual mechanism of action. It can selectively promote the slow inactivation of sodium channels and regulate collapse response...

Thursday 12 June 2025

Clemastine fumarate is a potent, long-acting, fast-acting, highly selective histamine H1 receptor antagonist that simultaneously blocks H1 receptors and antagonizes cytotoxicity. It is mainly used clinically for allergic diseases such as allergic skin diseases and allergic rhinitis...

Wednesday 11 June 2025

Quantité : 1kg; 25kg;

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Wednesday 11 June 2025

Quantité : 1kg; 25kg;

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Wednesday 11 June 2025

Quantité : 1kg; 25kg;

Tianeptine FA cas 72797-41-2 has antidepressant and anxiolytic (anti-anxiety) properties with a relative lack of sedative, anticholinergic and cardiovascular adverse effects, thus suggesting it is particularly suitable for use in the elderly and in those following withdrawal; such...

Wednesday 11 June 2025

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Wednesday 11 June 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Saturday 07 June 2025

Quantité : 1kg; 25kg;

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Saturday 07 June 2025

Quantité : 1kg; 25kg;

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...